Your browser doesn't support javascript.
loading
Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial.
Manomaipiboon, Anan; Pholtawornkulchai, Kittisak; Poopipatpab, Sujaree; Suraamornkul, Swangjit; Maneerit, Jakravoot; Ruksakul, Wiroj; Phumisantiphong, Uraporn; Trakarnvanich, Thananda.
Afiliação
  • Manomaipiboon A; Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand.
  • Pholtawornkulchai K; Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand.
  • Poopipatpab S; Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand.
  • Suraamornkul S; Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand.
  • Maneerit J; Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand.
  • Ruksakul W; Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand.
  • Phumisantiphong U; Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand.
  • Trakarnvanich T; Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand. thananda@hotmail.com.
Trials ; 23(1): 714, 2022 Aug 26.
Article em En | MEDLINE | ID: mdl-36028897

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article